Trial Details

Not recruiting
Basic Information
Clinical ID c2570
Identifier NCT04245215
Trial Title Loss of RESponse to Ustekinumab Treated by Dose Escalation
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Crohn Disease
Interventions Drug: Ustekinumab
Participant Information
Sponsor Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
City -
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Interventional
Phase PHASE3
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -